SG11202109635RA - Radiosensitizing agent - Google Patents
Radiosensitizing agentInfo
- Publication number
- SG11202109635RA SG11202109635RA SG11202109635RA SG11202109635RA SG 11202109635R A SG11202109635R A SG 11202109635RA SG 11202109635R A SG11202109635R A SG 11202109635RA SG 11202109635R A SG11202109635R A SG 11202109635RA
- Authority
- SG
- Singapore
- Prior art keywords
- radiosensitizing agent
- radiosensitizing
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7032—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a polyol, i.e. compounds having two or more free or esterified hydroxy groups, including the hydroxy group involved in the glycosidic linkage, e.g. monoglucosyldiacylglycerides, lactobionic acid, gangliosides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0038—Radiosensitizing, i.e. administration of pharmaceutical agents that enhance the effect of radiotherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N2005/1092—Details
- A61N2005/1098—Enhancing the effect of the particle by an injected agent or implanted device
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pathology (AREA)
- Radiology & Medical Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019039749A JP6621158B1 (ja) | 2019-03-05 | 2019-03-05 | 放射線増感剤 |
| PCT/JP2019/041730 WO2020179125A1 (ja) | 2019-03-05 | 2019-10-24 | 放射線増感剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202109635RA true SG11202109635RA (en) | 2021-10-28 |
Family
ID=68917196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202109635R SG11202109635RA (en) | 2019-03-05 | 2019-10-24 | Radiosensitizing agent |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20210393660A1 (ja) |
| EP (1) | EP3925611A4 (ja) |
| JP (1) | JP6621158B1 (ja) |
| CN (1) | CN113507939A (ja) |
| SG (1) | SG11202109635RA (ja) |
| WO (1) | WO2020179125A1 (ja) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6903273B1 (ja) | 2020-09-25 | 2021-07-14 | 株式会社エム・ティー・スリー | 化合物又はその塩、及び放射性増感剤 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0105285A3 (en) | 1999-02-08 | 2006-07-28 | Alza Corp Mountain View | Liposome composition and method for its preparation and its use |
| KR100832167B1 (ko) * | 2004-06-24 | 2008-05-23 | 토요 수이산 가부시키가이샤 | 방사선치료 증감제 |
| JP2007302609A (ja) | 2006-05-12 | 2007-11-22 | Pola Chem Ind Inc | 低酸素性細胞放射線増感剤における放射線増感能の増強剤 |
| EA016931B1 (ru) * | 2007-07-20 | 2012-08-30 | Тойо Суйсан Кайся, Лтд. | Новое сульфированное соединение сахара и его применение в качестве лекарственного средства |
| CA2749797A1 (en) * | 2009-01-16 | 2010-07-22 | Toyo Suisan Kaisha, Ltd. | Compound having tumor-resident property |
| JP2016150905A (ja) * | 2015-02-16 | 2016-08-22 | 学校法人東京理科大学 | チオアルドヘキソース誘導体及びその製造方法 |
| JP6281998B1 (ja) | 2017-08-24 | 2018-02-21 | 株式会社アナライズ | 検査用具 |
-
2019
- 2019-03-05 JP JP2019039749A patent/JP6621158B1/ja active Active
- 2019-10-24 EP EP19918427.6A patent/EP3925611A4/en active Pending
- 2019-10-24 CN CN201980093541.4A patent/CN113507939A/zh active Pending
- 2019-10-24 WO PCT/JP2019/041730 patent/WO2020179125A1/ja unknown
- 2019-10-24 SG SG11202109635R patent/SG11202109635RA/en unknown
-
2021
- 2021-09-03 US US17/465,921 patent/US20210393660A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN113507939A (zh) | 2021-10-15 |
| JP2020143006A (ja) | 2020-09-10 |
| US20210393660A1 (en) | 2021-12-23 |
| WO2020179125A1 (ja) | 2020-09-10 |
| JP6621158B1 (ja) | 2019-12-18 |
| EP3925611A1 (en) | 2021-12-22 |
| EP3925611A4 (en) | 2022-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL272291A (en) | Materials labeled with bicyclic radioisotopes and drugs | |
| EP3732195A4 (en) | CYTOTOXICITY-INDUCING THERAPEUTIC | |
| EP3619238A4 (en) | CYTOTOXICITY INDUCING THERAPEUTIC | |
| GB201814169D0 (en) | Blockchain autonoumous agents | |
| EP3850072C0 (de) | Silberschutzmittel | |
| EP3583934A4 (en) | BIOCIDAL AGENT | |
| GB201913756D0 (en) | Contrast agent | |
| SG11202109635RA (en) | Radiosensitizing agent | |
| GB201714777D0 (en) | Agent | |
| EP3831399A4 (en) | AGENT AGAINST NOROVIRUS | |
| SG11202006539RA (en) | Cytocidal agent | |
| ZA202103582B (en) | Dna-cutting agent | |
| ZA202103578B (en) | Dna-cutting agent | |
| CA195219S (en) | Overall | |
| SG11202110640UA (en) | Antimicrobial agent | |
| EP4077308C0 (en) | ANTI-MALARIA AGENTS | |
| PL3800215T3 (pl) | Środek dyspergujący | |
| GB201917052D0 (en) | Bioselection approach | |
| GB201917053D0 (en) | Bioselection approach | |
| GB201916328D0 (en) | Disclosure | |
| GB201916329D0 (en) | Disclosure | |
| GB201916327D0 (en) | Disclosure | |
| GB201912214D0 (en) | Disclosure | |
| GB201910662D0 (en) | Disclosure | |
| GB201909994D0 (en) | Disclosure |